Downgrade Alert for BioCryst Pharmaceuticals (BCRX)
February 09, 2016 at 09:16 AM EST
BioCryst Pharmaceuticals (NASDAQ:BCRX) was downgraded from Buy to Hold at Jefferies today. The stock closed yesterday at $1.78 on volume of 9.3 million shares, above average daily volume of...
